The CAR-NK cells kill CD70-positive tumor cells via CAR-triggered cytotoxicity (perforin/granzyme and death receptor pathways). IL-2Rβ is part of the IL-15 receptor on the engineered NK cells and provides survival/proliferation signals; cells expressing IL-2Rβ are not targeted for killing.